Gladstone Home spacer GICD
 
 
Supporting Gladstone
Research Milestones
  • Discovered a method to "reprogram" adult cells into embryonic stem-cell-like cells that can be redirected to form any cell type in the body
  • Explained fetal heart development and genetic causes of heart disease, providing new methods to turn stem cells or adult cells into beating heart cells
  • Helped lay the foundation for the first cholestrol-lowering therapies and for Integrilin, one of the most successful drugs for eliminating the blood clots that can lead to heart attack and stroke
  • Discovered a genetic cause of cardiac septal defects (holes in the heart) in humans, the most common cardiac malformation
  • Discovered genetic cause of aortic valve disease in humans, the third most common cause of adult heart disease
  • Discovered molecular pathway involved in differentiation of cardiomyocytes
  • Discovered molecular pathway involved in DiGeorge syndrome, the most common human genetic deletion syndrome
  • Determined the protein sequence of apolipoprotein (apo) E and the structural differences in apoE isoforms
  • Mapped the low density lipoprotein (LDL) receptor–binding region of apoE
  • Determined the apoE cDNA and gene sequence
  • Cloned the platelet glycoprotein IIIa
  • Determined of the x-ray crystal structure of apoE
  • Recognized the role of apoE in neuronal repair and maintenance
  • Determined the apoB cDNA sequence
  • Mapped the LDL receptor–binding region of apoB
  • Established the molecular mechanism of type III hyperlipoproteinemia
  • Defined the metabolism and cellular biology of apoB-containing lipoproteins
  • Cloned and sequenced the chemokine receptor MCP-1
  • Cloned and sequenced ACAT-2, an enzyme involved in intracellular cholesterol homeostasis
  • Cloned and sequenced DGAT, an enzyme responsible for triglyceride synthesis
  • Generated animal models of human disorders of lipid metabolism
  • Determined the role of the Gi signaling pathways in cardiomyopathy
  • Used gene-targeting in the artery wall to modify atherosclerosis
  • Developed novel animal models of arterial gene transfer and gene therapy
  • Studying the genetic epidemiology of low levels of high density lipoproteins (HDL) in the Turkish population
  • Defined interactions between the immune system and virus-mediated gene transfer
  • Developing a heart-healthy Special Program in Nutrition (SPIN) for third and fourth graders and their families
  • Defined the contribution of MCP-1 signaling to the development of atherosclerosis
  • Established a role for fractalkine (CX3CR1) in leukocyte adhesion

Gladstone Home | Cardiovascular Disease | Virology and Immunology | Neurological Disease | Administration | UCSF